Gene · 1445
Papers4,278
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,278
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Abl kinase-mediated FUS Tyr526 phosphorylation alters nucleocytoplasmic FUS localization in FTLD-FUS. | Brain | 2023 | 37071594 | PubTator, text mining | PubMed |
| The IQGAP scaffolds: Critical nodes bridging receptor activation to cellular signaling. | J Cell Biol | 2023 | 37071417 | PubTator, text mining | PubMed |
| A Genetic and Immunohistochemical Analysis of Helicobacter pylori Phenotypes and p27 Expression in Adenocarcinoma Patients in Jordan. | J Epidemiol Glob Health | 2023 | 37071369 | PubTator, text mining | PubMed |
| Tenth International Symposium on the Hsp90 chaperone machine : Switzerland, October 19-23, 2022. | Cell Stress Chaperones | 2023 | 37071341 | PubTator, text mining | PubMed |
| Styrylquinazoline derivatives as ABL inhibitors selective for different DFG orientations. | J Enzyme Inhib Med Chem | 2023 | 37070569 | PubTator, text mining | PubMed |
| Optimal combination of immune checkpoint and senescence molecule predicts adverse outcomes in patients with acute myeloid leukemia. | Ann Med | 2023 | 37070487 | PubTator, text mining | PubMed |
| Overview of the therapeutic strategies for ER positive breast cancer. | Biochem Pharmacol | 2023 | 37068524 | PubTator, text mining | PubMed |
| Detection of pre-existing neutralizing antibodies against Ad26 in HIV-1-infected individuals not responding to the Ad26.COV2.S vaccine. | Infection | 2023 | 37067754 | PubTator, text mining | PubMed |
| PRL3 as a therapeutic target for novel cancer immunotherapy in multiple cancer types. | Theranostics | 2023 | 37064866 | PubTator, text mining | PubMed |
| Exosomal miRNAs in the Tumor Microenvironment of Multiple Myeloma. | Cells | 2023 | 37048103 | PubTator, text mining | PubMed |
| THY1 (CD90) Maintains the Adherens Junctions in Nasopharyngeal Carcinoma via Inhibition of SRC Activation. | Cancers (Basel) | 2023 | 37046850 | PubTator, text mining | PubMed |
| Novel SLFN14 mutation associated with macrothrombocytopenia in a patient with severe haemorrhagic syndrome. | Orphanet J Rare Dis | 2023 | 37041648 | PubTator, text mining | PubMed |
| The effects of socioeconomic status on major adverse cardiovascular events: a nationwide population-based cohort study. | Kidney Res Clin Pract | 2023 | 37037483 | PubTator, text mining | PubMed |
| Global-feature of autoimmune glomerulonephritis using proteomic analysis of laser capture microdissected glomeruli. | Front Immunol | 2023 | 37033921 | PubTator, text mining | PubMed |
| Identification and Biological Evaluation of a Water-Soluble Fullerene Nanomaterial as BTK Kinase Inhibitor. | Int J Nanomedicine | 2023 | 37025922 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Focusing on discoidin domain receptors in premalignant and malignant liver diseases. | Front Oncol | 2023 | 37007062 | PubTator, text mining | PubMed |
| Tumor microenvironment signaling and therapeutics in cancer progression. | Cancer Commun (Lond) | 2023 | 37005490 | PubTator, text mining | PubMed |
| Developmental and homeostatic signaling transmitted by the G-protein coupled receptor FPR2. | Int Immunopharmacol | 2023 | 37003185 | PubTator, text mining | PubMed |
| Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options. | Mol Med | 2023 | 36991316 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1445/papers?page=15